Breaking News
Dead Simple Apocalypse Power: Build It in an Hour
Dear Friend of Liberty,
The American Dream Is Being Crushed: The Cost Of Living Is Spiraling Out Of Control And Millions...
Accused Charlie Kirk Assassin Tyler Robinson Won't Face A Jury Until 2028
Top Tech News
Musk's Starlink Is Building An Orbital Bypass As Undersea Cable Sabotage Threats Mount
A robot just built a structure in space for the first time
The Greatest Theft in Human History
3D-Printed Tungsten Survives 74 Fusion Plasma Discharges, Advancing the Engineering...
Dude turns a $23 used smartphone into the 4G brain of an RC aircraft.
China's World-Beating Supercar Just Hit 312 MPH
Pentagon Delivers 25,000+ Drones And Counter-Drone Systems To CENTCOM In A "Massive Surge"
Prism puts an eye-controlled Linux computer on your face
Remember Yesterday: AI For Today and Tomorrow
Robot Mowers Invade America's Golf Courses, Putting Groundskeepers On Notice
Nanotech platform Carries mRNA Directly to Target Cells
The groundbreaking method may prove useful in treating myriad malignancies, inflammatory diseases and rare genetic disorders.
Lipid nanoparticles (LNP) were used to deliver modified messenger RNA to treat inflammatory bowel diseases and other diseases.
Prof. Dan Peer, Molecular Cell Biology at TAU's Faculty of Life Sciences, led the research for the new study.
Over the past few years, lipid carriers encapsulating messenger RNAs (mRNAs) have been shown to be extremely useful in altering the protein expressions for a host of diseases. But directing this information to specific cells has remained a major challenge.
"In our new research, we utilized mRNA-loaded carriers — nanovehicles carrying a set of genetic instructions via a biological platform called ASSET — to target the genetic instructions of an anti-inflammatory protein in immune cells," says Prof. Peer.